XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(Q3)Dec 31, 2004 | (Q2)Sep 30, 2004 | (Q1)Jun 30, 2004 | (FY)Mar 31, 2004 | (Q4)Mar 31, 2004 | (Q3)Dec 31, 2003 | (Q2)Sep 30, 2003 | (Q1)Jun 30, 2003 | (FY)Mar 31, 2003 | (Q4)Mar 31, 2003 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -88.92%43K | -99.76%2K | -99.72%3K | -99.41%8K | -99.41%8K | -71.07%388K | -52.88%851K | -52.22%1.08M | -54.12%1.35M | -54.12%1.35M |
-Cash and cash equivalents | -88.92%43K | -99.76%2K | -99.72%3K | -99.41%8K | -99.41%8K | -71.07%388K | -52.88%851K | -52.22%1.08M | -54.12%1.35M | -54.12%1.35M |
Receivables | --0 | --0 | ---- | -88.89%19K | -88.89%19K | 3.09%100K | 353.03%299K | -53.54%177K | 180.33%171K | 180.33%171K |
-Accounts receivable | --0 | --0 | ---- | -88.89%19K | -88.89%19K | 3.09%100K | 353.03%299K | -53.54%177K | 180.33%171K | 180.33%171K |
Other current assets | ---- | ---- | -94.85%5K | -64.41%21K | -64.41%21K | 47.87%139K | -25.23%83K | -35.76%97K | -43.81%59K | -43.81%59K |
Total current assets | -93.14%43K | -99.84%2K | -99.41%8K | -96.95%48K | -96.95%48K | -59.07%627K | -37.82%1.23M | -51.51%1.35M | -49.16%1.58M | -49.16%1.58M |
Non current assets | ||||||||||
Net PPE | --0 | --0 | ---- | ---- | ---- | -78.30%74K | -78.36%95K | -77.58%102K | -74.35%129K | -74.35%129K |
-Gross PPE | --0 | --0 | ---- | ---- | ---- | -26.72%776K | -31.11%797K | -31.46%804K | -31.94%831K | -31.94%831K |
-Accumulated depreciation | ---- | ---- | ---- | ---- | ---- | 2.23%-702K | 2.23%-702K | 2.23%-702K | 2.23%-702K | 2.23%-702K |
Other non current assets | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%46K | --46K | 475.00%46K | 475.00%46K |
Total non current assets | --0 | --0 | --0 | --0 | --0 | -80.88%74K | -70.93%141K | -67.47%148K | -65.75%175K | -65.75%175K |
Total assets | -93.87%43K | -99.85%2K | -99.47%8K | -97.26%48K | -97.26%48K | -63.47%701K | -44.33%1.37M | -53.75%1.5M | -51.51%1.75M | -51.51%1.75M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | ---- | ---- | -72.78%190K | -73.40%195K | -73.40%195K | -13.29%646K | 0.41%741K | -11.65%698K | -19.36%733K | -19.36%733K |
-accounts payable | ---- | ---- | -72.78%190K | -73.40%195K | -73.40%195K | -13.29%646K | 0.41%741K | -11.65%698K | -19.36%733K | -19.36%733K |
Current debt and capital lease obligation | --290K | --168K | --168K | --25K | --25K | ---- | ---- | ---- | ---- | ---- |
-Current debt | --290K | --168K | --168K | --25K | --25K | ---- | ---- | ---- | ---- | ---- |
Current deferred liabilities | ---- | ---- | ---- | ---- | ---- | -54.62%54K | -22.66%99K | -11.28%299K | -55.76%146K | -55.76%146K |
Current liabilities | -30.14%489K | -56.31%367K | -64.09%358K | -74.97%220K | -74.97%220K | -18.98%700K | -3.00%840K | -11.54%997K | -29.06%879K | -29.06%879K |
Non current liabilities | ||||||||||
Total non current liabilities | --0 | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Total liabilities | -30.14%489K | -56.31%367K | -64.09%358K | -74.97%220K | -74.97%220K | -18.98%700K | -3.00%840K | -11.54%997K | -29.06%879K | -29.06%879K |
Shareholders'equity | ||||||||||
Share capital | 0.00%13K | 0.00%13K | 44.44%13K | 44.44%13K | 44.44%13K | 44.44%13K | 44.44%13K | 0.00%9K | 0.00%9K | 0.00%9K |
-common stock | 0.00%13K | 0.00%13K | 44.44%13K | 44.44%13K | 44.44%13K | 44.44%13K | 44.44%13K | 0.00%9K | 0.00%9K | 0.00%9K |
Retained earnings | -2.00%-25.84M | -3.85%-25.76M | -5.63%-25.75M | -6.52%-25.57M | -6.52%-25.57M | -6.36%-25.34M | -6.60%-24.81M | -7.08%-24.37M | -6.76%-24M | -6.76%-24M |
Paid-in capital | 0.24%25.38M | 0.22%25.38M | 2.08%25.38M | 2.08%25.38M | 2.08%25.38M | 1.84%25.32M | 1.86%25.33M | 0.00%24.87M | 0.43%24.87M | 0.43%24.87M |
Total stockholders'equity | -44,700.00%-446K | -168.35%-365K | -169.86%-350K | -119.72%-172K | -119.72%-172K | -99.91%1K | -66.67%534K | -76.28%501K | -63.24%872K | -63.24%872K |
Total equity | -44,700.00%-446K | -168.35%-365K | -169.86%-350K | -119.72%-172K | -119.72%-172K | -99.91%1K | -66.67%534K | -76.28%501K | -63.24%872K | -63.24%872K |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |